Daniel J. George, Noel W. Clarke, Maria de Santis, Hirotsugu Uemura, Andre P. Fay, Yüksel Ürün, Cagatay Arslan, Jun Hyuk Hong, Jae Young Joung, Wei Chen, Karl Lesage, Nguyen Thi Thai Hoa, Velko Minchev, Gabriel Garbaos, Jill Logan, Louise Newton, Jody Koepp-Norris, Mahmuda Khatun, Karim Fizazi. "Patient reported outcomes (PRO) and tolerability of capivasertib (capi) plus abiraterone (abi) versus placebo (pbo) plus abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC): CAPItello-281.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.14